Document Detail


Control of sudden recurrent arrhythmic deaths: role of amiodarone.
MedLine Citation:
PMID:  6613836     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patients resuscitated after out-of-hospital cardiac arrest have electrical instability of the myocardium, with 30% to 40% propensity for recurrent arrest in the first year. About 85% to 90% of such patients have complex ventricular ectopy and runs of ventricular tachycardia; in 70% to 80%, ventricular tachycardia or fibrillation are inducible by programmed electrical stimulation. The attempt to control recurrent cardiac arrest using these parameters and conventional antiarrhythmic drugs has yielded conflicting or variable results. Amiodarone was therefore studied in 40 consecutive patients (with previous cardiac arrests) in whom conventional antiarrhythmic therapy had proved ineffective or was not tolerated. The mean ejection fraction of the group was 0.29 +/- 0.12. At a mean follow-up of 16 months (range 5 to 40 months) six patients had died, three from heart failure, one from liver failure (not drug induced), and two from sudden (presumably arrhythmic) death. Late occurrences of arrhythmia were found in two patients (complicated by digitalis intoxication in one). Ambulatory ECG recordings showed that amiodarone had a potent suppressant effect on ventricular ectopy and runs of VT, but electrophysiologic studies demonstrated that it did not inhibit inducible VT/VF in greater than 65% despite an excellent clinical outcome. Limiting adverse reaction was seen in only one patient; other relatively minor side effects occurred in 10% to 15% of patients receiving maintenance therapy. Our data provide further evidence for the effectiveness of amiodarone in life-threatening ventricular arrhythmias, with a potential for the prolongation of survival in patients resuscitated after out-of-hospital cardiac arrests.
Authors:
K Nademanee; B N Singh; D S Cannom; J Weiss; G Feld; W G Stevenson
Related Documents :
18753546 - 474385 - perioperative cardiac arrests in a southeast asian university teaching hospita...
7376826 - Hypotensive brain stem necrosis or cardiac arrest encephalopathy?
3885296 - Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest.
8809916 - Unexpected return of cardiac action after termination of cardiopulmonary resuscitation.
19474056 - Heart rate as a treatable cardiovascular risk factor.
21411206 - Long-term changes in left ventricular function following intracoronary stem cell transp...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American heart journal     Volume:  106     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1983 Oct 
Date Detail:
Created Date:  1983-10-28     Completed Date:  1983-10-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  895-901     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amiodarone / adverse effects,  therapeutic use*
Anti-Arrhythmia Agents / therapeutic use
Arrhythmias, Cardiac / drug therapy,  mortality*,  physiopathology
Benzofurans / therapeutic use*
Electric Stimulation
Electrophysiology
Heart Ventricles / physiopathology
Humans
Ventricular Fibrillation / physiopathology
Grant Support
ID/Acronym/Agency:
HL23970-03/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Benzofurans; 1951-25-3/Amiodarone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fi...
Next Document:  Ocular effects in long-term amiodarone therapy.